A Memorial Sloan-Kettering team has conducted one of the first large-scale screens of a small molecule library in neuronal cells obtained by differentiating patient-derived iPS cells. Separately, a partnership led by Roche and the University of Oxford is aiming to establish a repository of iPS cells from 500 patients with diabetes or various neurological diseases.